scholarly journals Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells

2009 ◽  
Vol 11 (6) ◽  
pp. 653-661 ◽  
Author(s):  
Tze-Chen Hsieh
Molecules ◽  
2017 ◽  
Vol 22 (2) ◽  
pp. 210 ◽  
Author(s):  
Laure-Estelle Cassagnes ◽  
Nambinina Rakotoarivelo ◽  
Serena Sirigu ◽  
Pierre Pério ◽  
Ennaji Najahi ◽  
...  

2008 ◽  
Vol 11 (3-4) ◽  
pp. 242-259 ◽  
Author(s):  
Donald T. Wigle ◽  
Michelle C. Turner ◽  
James Gomes ◽  
Marie-Élise Parent

2014 ◽  
Vol 1843 (9) ◽  
pp. 1839-1850 ◽  
Author(s):  
Yuyang Sun ◽  
Pramod Sukumaran ◽  
Archana Varma ◽  
Susan Derry ◽  
Abe E. Sahmoun ◽  
...  

2006 ◽  
Vol 1090 (1) ◽  
pp. 113-119
Author(s):  
I GRBAVAC ◽  
C WOLF ◽  
N WENDA ◽  
D ALBER ◽  
M KUHBACHER ◽  
...  

Urology ◽  
2011 ◽  
Vol 78 (3) ◽  
pp. S41
Author(s):  
Y. Mitsui ◽  
M. Hiraki ◽  
N. Arichi ◽  
T. Hiraoka ◽  
M. Sumura ◽  
...  

2006 ◽  
Vol 169 (5) ◽  
pp. 1843-1854 ◽  
Author(s):  
Thomas A. Dunn ◽  
Shenglin Chen ◽  
Dennis A. Faith ◽  
Jessica L. Hicks ◽  
Elizabeth A. Platz ◽  
...  

2000 ◽  
Vol 24 (3) ◽  
pp. 339-351 ◽  
Author(s):  
AS Waller ◽  
RM Sharrard ◽  
P Berthon ◽  
NJ Maitland

In vitro models of normal and malignant human prostate are currently limited to a few well established cell lines that, with a single exception (LNCaP), fail to express the androgen receptor (AR) - a common characteristic of prostatic epithelium grown in culture. To investigate the molecular mechanism of action of the non-steroidal antiandrogen Casodex (bicalutamide) against wild-type AR, we have established a transient AR expression model in non-tumorigenic prostate cells of both epithelial and mesenchymal origin. In this model, both dihydrotestosterone and Casodex can effectively transport the AR protein into the nucleus of prostate cells. Whereas the natural ligand, dihydrotestosterone, stabilises the receptor, the AR is rapidly degraded at a nuclear location when the transfected cells are treated with Casodex. In contrast, whereas the mutant AR in the LNCaP line is also degraded on Casodex treatment over the same time period, its intracellular targeting is defective.


Sign in / Sign up

Export Citation Format

Share Document